Schnieders Capital Management, Llc.
Source: SEC Form 13F · as of Mar 2026Schnieders Capital Management, Llc. holds 15 biotech & pharma companies tracked by BioSniper, totaling $49.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$49.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 71,328 | $17.4M |
| AMGNAMGEN INC | 25,721 | $9.1M |
| LLYELI LILLY & Co | 8,479 | $7.8M |
| ABTABBOTT LABORATORIES | 49,851 | $5.1M |
| ABBVAbbVie Inc. | 16,234 | $3.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,389 | $2.0M |
| PMPhilip Morris International Inc | 10,002 | $1.7M |
| MRKMerck & Co., Inc. | 8,060 | $969K |
| BMYBRISTOL MYERS SQUIBB CO | 8,219 | $498K |
| DGXQuest Diagnostics Incorporated | 1,817 | $356K |
| PFEPFIZER INC | 10,868 | $305K |
| NVONovo Nordisk A/S | 7,751 | $285K |
| NVSNovartis AG | 1,759 | $269K |
| ELVElevance Health Inc. | 776 | $227K |
| CGENCOMPUGEN LTD | 50,000 | $107K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.